Managing Type 2 Diabetes and CV risk
Diabetes approximately doubles the risk for a range of cardiovascular diseases independently of traditional risk factors.
Cardiovascular disease (CVD) is the leading cause of death in people with diabetes, with nearly 11,900 Australian deaths in 2005 of which CVD was involved in more than 50%: coronary heart disease (CHD) (48%), and stroke (16%).
This clinical audit will allow you to review your current management of patients with type 2 diabetes at risk of cardiovascular disease, and compare it with best practice guidelines.
On successful completion, GPs will be eligible for 40 Category 1 points from the RACGP, or 30 PRPD points from ACRRM. This audit qualifies as a Quality Improvement activity.
By completing this audit, GPs will be able to:
- Identify current treatment targets for BP, lipids, weight, and HbA1c for T2DM patients with CVD according to latest guidelines
- Update knowledge on evidence of oral anti-diabetic agents to lower risk of CVD in these patients
- Demonstrate a knowledge of the range of options available for treatment of T2DM and cardio-protection to ensure both conditions are appropriately managed
- Develop a systematic management plan for T2DM and CVD (or at risk of CV disease) patients to ensure patient safety
Click here to start the Audit